Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 37, 2023 - Issue 4
297
Views
3
CrossRef citations to date
0
Altmetric
Short Communications

Diterpenoids profile of the marine sponge Chelonaplysilla erecta and candidacy as potential antitumor drugs investigated by molecular docking and pharmacokinetic studies

, , , , , , , , , & show all
Pages 598-602 | Received 25 Jan 2022, Accepted 02 Apr 2022, Published online: 10 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lamya H. Al-Wahaibi, Mohamed A. Mahmoud, Yaser A. Mostafa, Ali E. Raslan & Bahaa G. M. Youssif. (2023) Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1, pages 376-386.
Read now

Articles from other publishers (2)

Hesham A. Abou‐Zied, Eman A. M. Beshr, Hesham A. M. Gomaa, Yaser A. Mostafa, Bahaa G. M. Youssif, Alaa M. Hayallah & Mohamed Abdel‐Aziz. (2022) Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF V600E with promising antiproliferative properties . Archiv der Pharmazie 356:4.
Crossref
Noha M. Gamaleldin, Hebatallah S. Bahr, Yaser A. Mostafa, Bryant F. McAllister, Amr El Zawily, Che J. Ngwa, Gabriele Pradel, Hossam M. Hassan, Usama Ramadan Abdelmohsen, Dalal Hussien M. Alkhalifah & Wael N. Hozzein. (2022) Metabolomic Profiling, In Vitro Antimalarial Investigation and In Silico Modeling of the Marine Actinobacterium Strain Rhodococcus sp. UR111 Associated with the Soft Coral Nephthea sp.. Antibiotics 11:11, pages 1631.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.